Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Trial details
- Registry ID
- NCT07704099
- Drugs studied
- KER-065
TrialRedline tracks 2 clinical trials sponsored by Keros Therapeutics, Inc.: 2 Phase 2.
Company identity checked against sources
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Safety and Efficacy of KER-065 in Participants With Duchenne Muscular DystrophyNCT07704099 | KER-065 | Recruiting | 2028-08-26Estimated |
| A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).NCT05975905 | Dose A KER-012, Dose B KER-012, Dose C KER-012 | Terminated | 2025-03-05Actual |
Names as written in the registry records.
Before: Completed. After: Terminated.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Change from Baseline in PVR (Pulmonary Vascular Resistance). After: Measure: Change From Baseline in PVR (Pulmonary Vascular Resistance).